Lahore: Highnoon Laboratories Limited has announced that its Board of Directors will convene on February 02, 2026, at 11:00 a.m. at the company's corporate office in Lahore. The meeting is set to focus on the approval of the annual budget for the fiscal year 2026 alongside other agenda items.

In compliance with regulatory requirements, Highnoon Laboratories has declared a "Closed Period" from January 26, 2026, to February 02, 2026. During this time frame, no Director, CEO, or Executive is permitted to engage in any form of trading involving the company's shares. This decision aligns with clause 5.6.4. of the Pakistan Stock Exchange (PSX) Regulations, ensuring the integrity and confidentiality of sensitive financial information.

According to information available from the Pakistan Stock Exchange (PSX), the implementation of a closed period is a standard procedure for publicly traded companies when confidential financial discussions are imminent. This measure is intended to prevent insider trading and maintain market fairness.

The board meeting on February 02 will be a pivotal event for Highnoon Laboratories as it charts its financial course for the upcoming fiscal year. The outcomes of this meeting are anticipated to have significant implications for the company’s operations and strategic direction.